Related Experiment Video
Updated: Aug 12, 2025
05:57
Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
Published on: August 2, 2022
4.3K
Plasma Cell Vulvitis Treated with Platelet-rich Plasma: A Case Report
Paras Oli1, Harihar Adhikari2, Deeptara Pathak Thapa2
1Nepal Medical College and Teaching Hospital, Jorpati, Kathmandu, Nepal.
JNMA; Journal of the Nepal Medical Association
|January 27, 2023
Summary
Plasma cell vulvitis, a rare vulvar inflammation, often resists standard treatments. Platelet-rich plasma therapy showed promising results in a refractory case, offering a new option for this condition.
Area of Science:
- Dermatology
- Gynecology
Background:
- Plasma cell vulvitis is a rare, poorly understood inflammatory condition affecting the vulva.
- It presents with symptoms like pain, itching, and dyspareunia, and clinical signs of erythema.
Observation:
- A 70-year-old female patient with histopathologically confirmed plasma cell vulvitis was treated.
Findings:
- The patient had previously failed treatment with topical steroids and immunomodulators.
- Treatment with platelet-rich plasma resulted in significant symptomatic and clinical improvement.
Implications:
- Platelet-rich plasma therapy represents a novel and potentially effective treatment for recalcitrant plasma cell vulvitis.
- This case highlights a new therapeutic avenue for patients unresponsive to conventional therapies.
